Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | TANG CAPITAL MANAGEMENT, LLC | 766,940 2.800% | 766,940 (New Position) | Filing History |
| 2024-11-08 5:08 pm Unchanged | 2024-08-14 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 2,101,199 7.600% | 0 (Unchanged) | Filing History |
| 2024-07-29 4:12 pm Purchase | 2024-07-17 | 13G | LENZ Therapeutics, Inc. LENZ | Ridgeback Capital Investments L.P. | 1,951,875 7.200% | 1,951,875 (New Position) | Filing History |
| 2024-04-08 2:46 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | EcoR1 Capital, LLC | 1,219,774 4.800% | 1,219,774 (New Position) | Filing History |
| 2024-03-28 4:30 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Alpha Wave Ventures GP Ltd | 3,612,211 14.100% | 3,612,211 (New Position) | Filing History |
| 2024-03-28 4:16 pm Purchase | 2024-03-21 | 13D | LENZ Therapeutics, Inc. LENZ | RA Capital Management, L.P. | 4,250,856 16.600% | 4,250,856 (New Position) | Filing History |
| 2024-03-25 8:42 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Samsara BioCapital, L.P. | 1,213,865 4.800% | 1,213,865 (New Position) | Filing History |
| 2024-03-25 4:43 pm Purchase | 2024-03-21 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 2,101,199 8.200% | 2,101,199 (New Position) | Filing History |
| 2024-03-25 4:33 pm Purchase | 2024-03-21 | 13G | LENZ Therapeutics, Inc. LENZ | Point72 Asset Management, L.P. | 1,882,693 7.400% | 1,882,693 (New Position) | Filing History |
| 2024-02-05 4:48 pm Purchase | 2024-01-24 | 13G | Graphite Bio, Inc. GRPH | TANG CAPITAL MANAGEMENT, LLC | 445,406 5.400% | 445,406 (New Position) | Filing History |
| 2024-02-05 4:31 pm Purchase | 2023-12-31 | 13G | Graphite Bio, Inc. GRPH | Porteus Matthew | 506,933 6.100% | 2,857 (+0.57%) | Filing History |
| 2023-11-17 4:38 pm Unchanged | 2023-11-14 | 13D | Graphite Bio, Inc. GRPH | Versant Venture Capital VI, L.P. | 2,101,200 25.400% | 0 (Unchanged) | Filing History |
| 2023-02-14 5:07 pm Purchase | 2022-12-31 | 13G | Graphite Bio, Inc. GRPH | Samsara BioCapital, L.P. | 1,213,867 14.600% | 92,162 (+8.22%) | Filing History |
| 2023-01-09 4:26 pm Purchase | 2023-01-06 | 13G | Graphite Bio, Inc. GRPH | EcoR1 Capital, LLC | 1,219,778 14.700% | 403,764 (+49.48%) | Filing History |
| 2022-12-12 08:41 am Sale | 2022-12-09 | 13G | Graphite Bio, Inc. GRPH | FMR LLC | 239,049 2.877% | -653,478 (-73.22%) | Filing History |
| 2022-11-18 1:40 pm Purchase | 2022-11-11 | 13G | Graphite Bio, Inc. GRPH | EcoR1 Capital, LLC | 816,014 9.800% | 816,014 (New Position) | Filing History |
| 2022-02-14 4:19 pm Purchase | 2021-12-31 | 13G | Graphite Bio, Inc. GRPH | Porteus Matthew | 504,076 6.100% | 504,076 (New Position) | Filing History |
| 2022-02-14 06:06 am Purchase | 2021-12-31 | 13G | Graphite Bio, Inc. GRPH | Samsara BioCapital, L.P. | 1,121,705 13.500% | 60,044 (+5.66%) | Filing History |
| 2022-02-09 09:19 am Sale | 2022-02-08 | 13G | Graphite Bio, Inc. GRPH | FMR LLC | 892,527 10.757% | -274 (-0.03%) | Filing History |
| 2021-10-12 09:25 am Purchase | 2021-10-08 | 13G | Graphite Bio, Inc. GRPH | FMR LLC | 892,801 10.760% | 892,801 (New Position) | Filing History |